0.015062 0.000000 0.000000 0.000000 0.015062 0.000000 0.000000 0.000000 0.014548 0.00000 0.00000 0.00000 Moncalian, G. Cardenes, N. Deribe, Y.L. Spinola-Amilibia, M. Dikic, I. Bravo, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 16 90.00 90.00 90.00 66.391 66.391 68.736 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Biol.Chem. JBCHA3 0071 0021-9258 281 38845 10.1074/JBC.M606411200 17020880 Atypical Polyproline Recognition by the Cms N-Terminal SH3 Domain. 2006 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 110.0 1 MIRRORS CCD 2004-06-07 MARRESEARCH SINGLE WAVELENGTH M x-ray 1 1.54179 1.0 1.54179 ROTATING ANODE ENRAF-NONIUS FR591 7412.285 CD2-ASSOCIATED PROTEIN SH3 DOMAIN, RESIDUES 1-62 1 man polymer 1119.382 T-CELL SURFACE ANTIGEN CD2 CMS BINDING SEQUENCE, RESIDUES 324-333 1 syn polymer 18.015 water 46 nat water CAS LIGAND WITH MULTIPLE SH3 DOMAINS, ADAPTER PROTEIN CMS, CMS T-CELL SURFACE ANTIGEN T11/LEU-5, LFA-2, LFA-3 RECEPTOR, ERYTHROCYTE RECEPTOR, ROSETTE RECEPTOR, CD2 no no MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETE MVDYIVEYDYDAVHDDELTIRVGEIIRNVKKLQEEGWLEGELNGRRGMFPDNFVKEIKRETE A polypeptide(L) no no KGPPLPRPRV KGPPLPRPRV C polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n HUMAN sample 9606 HOMO SAPIENS 469008 ESCHERICHIA COLI BL21(DE3) PET21 1 2.34 47.42 5.50 20% PEG3000, 0.1M ACETATE PH 5.5 diffrn_source repository Initial release Version format compliance Version format compliance Data collection 1 0 2006-10-11 1 1 2011-05-08 1 2 2011-07-13 1 3 2017-07-05 _diffrn_source.type N-GLYCAN AND POLYPEPTIDE NMR SOLUTION STRUCTURES OF THE ADHESION DOMAIN OF HUMAN CD2 CD2 (HUMAN) CD2BP2-GYF DOMAIN IN COMPLEX WITH PROLINE- RICH CD2 TAILSEGMENT PEPTIDE N-TERMINAL SH3 DOMAIN OF CIN85 BOUND TO CBL-B PEPTIDE N-TERMINAL SH3 DOMAIN OF CMS (CD2AP HUMAN HOMOLOG) BOUND TO CBL-B PEPTIDE N-TERMINAL SH3 DOMAIN OF CMS (CD2AP HUMAN HOMOLOG) ATYPICAL POLYPROLINE RECOGNITION BY THE CMS N-TERMINAL SH3 DOMAIN.CMS:CD2 HETERODIMER PDBE Y PDBE 2006-10-02 REL HOH water 9606 HUMAN HOMO SAPIENS sample HOH 2001 3 HOH HOH 2001 A HOH 2002 3 HOH HOH 2002 A HOH 2003 3 HOH HOH 2003 A HOH 2004 3 HOH HOH 2004 A HOH 2005 3 HOH HOH 2005 A HOH 2006 3 HOH HOH 2006 A HOH 2007 3 HOH HOH 2007 A HOH 2008 3 HOH HOH 2008 A HOH 2009 3 HOH HOH 2009 A HOH 2010 3 HOH HOH 2010 A HOH 2011 3 HOH HOH 2011 A HOH 2012 3 HOH HOH 2012 A HOH 2013 3 HOH HOH 2013 A HOH 2014 3 HOH HOH 2014 A HOH 2015 3 HOH HOH 2015 A HOH 2016 3 HOH HOH 2016 A HOH 2017 3 HOH HOH 2017 A HOH 2018 3 HOH HOH 2018 A HOH 2019 3 HOH HOH 2019 A HOH 2020 3 HOH HOH 2020 A HOH 2021 3 HOH HOH 2021 A HOH 2022 3 HOH HOH 2022 A HOH 2023 3 HOH HOH 2023 A HOH 2024 3 HOH HOH 2024 A HOH 2025 3 HOH HOH 2025 A HOH 2026 3 HOH HOH 2026 A HOH 2027 3 HOH HOH 2027 A HOH 2028 3 HOH HOH 2028 A HOH 2029 3 HOH HOH 2029 A HOH 2030 3 HOH HOH 2030 A HOH 2031 3 HOH HOH 2031 A HOH 2032 3 HOH HOH 2032 A HOH 2033 3 HOH HOH 2033 A HOH 2034 3 HOH HOH 2034 A HOH 2035 3 HOH HOH 2035 A HOH 2036 3 HOH HOH 2036 A HOH 2037 3 HOH HOH 2037 A HOH 2038 3 HOH HOH 2038 A HOH 2039 3 HOH HOH 2039 A HOH 2040 3 HOH HOH 2040 A HOH 2041 3 HOH HOH 2041 A HOH 2042 3 HOH HOH 2042 A HOH 2043 3 HOH HOH 2043 A HOH 2044 3 HOH HOH 2044 A HOH 2001 3 HOH HOH 2001 C HOH 2002 3 HOH HOH 2002 C n 1 1 A VAL 2 n 2 VAL 2 A ASP 3 n 3 ASP 3 A TYR 4 n 4 TYR 4 A ILE 5 n 5 ILE 5 A VAL 6 n 6 VAL 6 A GLU 7 n 7 GLU 7 A TYR 8 n 8 TYR 8 A ASP 9 n 9 ASP 9 A TYR 10 n 10 TYR 10 A ASP 11 n 11 ASP 11 A ALA 12 n 12 ALA 12 A VAL 13 n 13 VAL 13 A HIS 14 n 14 HIS 14 A ASP 15 n 15 ASP 15 A ASP 16 n 16 ASP 16 A GLU 17 n 17 GLU 17 A LEU 18 n 18 LEU 18 A THR 19 n 19 THR 19 A ILE 20 n 20 ILE 20 A ARG 21 n 21 ARG 21 A VAL 22 n 22 VAL 22 A GLY 23 n 23 GLY 23 A GLU 24 n 24 GLU 24 A ILE 25 n 25 ILE 25 A ILE 26 n 26 ILE 26 A ARG 27 n 27 ARG 27 A ASN 28 n 28 ASN 28 A VAL 29 n 29 VAL 29 A LYS 30 n 30 LYS 30 A LYS 31 n 31 LYS 31 A LEU 32 n 32 LEU 32 A GLN 33 n 33 GLN 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A GLY 36 n 36 GLY 36 A TRP 37 n 37 TRP 37 A LEU 38 n 38 LEU 38 A GLU 39 n 39 GLU 39 A GLY 40 n 40 GLY 40 A GLU 41 n 41 GLU 41 A LEU 42 n 42 LEU 42 A ASN 43 n 43 ASN 43 A GLY 44 n 44 GLY 44 A ARG 45 n 45 ARG 45 A ARG 46 n 46 ARG 46 A GLY 47 n 47 GLY 47 A MET 48 n 48 MET 48 A PHE 49 n 49 PHE 49 A PRO 50 n 50 PRO 50 A ASP 51 n 51 ASP 51 A ASN 52 n 52 ASN 52 A PHE 53 n 53 PHE 53 A VAL 54 n 54 VAL 54 A LYS 55 n 55 LYS 55 A GLU 56 n 56 GLU 56 A ILE 57 n 57 ILE 57 A LYS 58 n 58 LYS 58 A n 59 59 A n 60 60 A n 61 61 A n 62 62 A n 1 324 C n 2 325 C n 3 326 C PRO 327 n 4 PRO 327 C LEU 328 n 5 LEU 328 C PRO 329 n 6 PRO 329 C ARG 330 n 7 ARG 330 C PRO 331 n 8 PRO 331 C ARG 332 n 9 ARG 332 C VAL 333 n 10 VAL 333 C author_and_software_defined_assembly PQS 2 dimeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N PHE 49 A N PHE 49 A O LEU 38 A O LEU 38 A N GLU 41 A N GLU 41 A O ARG 27 A O ARG 27 A N ILE 26 A N ILE 26 A O TYR 4 A O TYR 4 A N ILE 5 A N ILE 5 A O LYS 55 A O LYS 55 1 A HOH 2002 C HOH 1 A MET 1 A MET 1 1 Y 1 A ARG 59 A ARG 59 1 Y 1 A GLU 60 A GLU 60 1 Y 1 A THR 61 A THR 61 1 Y 1 A GLU 62 A GLU 62 1 Y 1 C LYS 324 B LYS 1 1 Y 1 C GLY 325 B GLY 2 1 Y 1 C PRO 326 B PRO 3 1 Y 1 3.01 0.50 120.30 123.31 C C C NE CZ NH1 ARG ARG ARG 330 330 330 N 1 C C CZ NH1 ARG ARG 330 330 0.089 0.013 1.326 1.415 N 1 A VAL 22 -38.12 124.98 1 A GLU 34 -52.31 108.81 1 C PRO 329 -74.88 -167.43 24.85 -0.21000 0.00000 0.00000 -0.21000 0.00000 0.42000 0.907 0.891 HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. THE BIOLOGICAL UNIT OF THIS STRUCTURE IS A HETEROTRIMER CONSISTING OF TWO CMS SH3A DOMAINS AND ONE CD2 PEPTIDE IN TWO ORIENTATIONS, WITH 0.5 OCCUPANCY EACH. THE SECOND CMS SH3A MOLECULES, AS WELL AS THE SECOND ORIENTATION OF THE PEPTIDE, ARE RELATED TO THAT IN THE ASYMMETRIC UNIT BY A CRYSTALLOGRAPHIC SYMMETRY OPERATION. 0.286 0.241 0.243 2.23 47.73 177 3932 4.520 98.1 8.792 0.211 RANDOM 1 THROUGHOUT 0.000 MOLECULAR REPLACEMENT 0.361 0.259 0.80 0.80 1.40 CMSA-CBL-B STRUCTURE MAXIMUM LIKELIHOOD BABINET MODEL PLUS MASK 2.23 47.73 46 580 0 0 534 0.010 0.022 562 1.306 1.974 762 5.750 5.000 68 29.944 24.062 32 16.883 15.000 104 17.052 15.000 6 0.077 0.200 82 0.004 0.020 432 0.201 0.200 220 0.304 0.200 353 0.172 0.200 33 0.256 0.200 31 0.196 0.200 10 1.482 3.000 335 2.310 4.000 534 2.058 4.000 254 3.007 6.000 225 0.3390 0.4050 47.73 3 59 20 33.00 2.220 34.360 2J6O 3933 0.000 0.11000 1 25.0200 16.660 98.0 0.41000 2.22 2.26 15.740 1 14.22 86.6 refinement REFMAC 5.2.0019 data reduction MOSFLM data scaling TRUNCATE phasing AMoRE CD2-ASSOCIATED PROTEIN, T-CELL SURFACE ANTIGEN CD2 ATYPICAL POLYPROLINE RECOGNITION BY THE CMS N-TERMINAL SH3 DOMAIN. CMS:CD2 HETEROTRIMER 1 N N 2 N N 3 N N 3 N N A ASP 51 A ASP 51 HELX_P A PHE 53 A PHE 53 5 1 3 PROTEIN BINDING PHOSPHORYLATION, ADAPTOR PROTEIN, EGFR DOWNREGULATION, CMS, SH3 DOMAIN, SH3-BINDING, COILED COIL, SH3 DOMAIN RECOGNITION, SIGNALING PROTEIN, PROTEIN BINDING CD2AP_HUMAN UNP 1 Q9Y5K6 CD2_HUMAN UNP 2 P06729 1 62 2J6O 1 62 Q9Y5K6 A 1 1 62 324 333 2J6O 324 333 P06729 C 2 1 10 5 anti-parallel anti-parallel anti-parallel anti-parallel A ARG 45 A ARG 45 A PRO 50 A PRO 50 A TRP 37 A TRP 37 A LEU 42 A LEU 42 A ILE 25 A ILE 25 A LYS 31 A LYS 31 A TYR 4 A TYR 4 A VAL 6 A VAL 6 A VAL 54 A VAL 54 A GLU 56 A GLU 56 97 I 4 2 2